COVID-19 in transplant recipients: The Spanish experience

被引:152
|
作者
Coll, Elisabeth [1 ]
Fernandez-Ruiz, Mario [2 ,3 ]
Sanchez-Alvarez, J. Emilio [4 ,5 ]
Martinez-Fernandez, Jose R. [1 ]
Crespo, Marta [6 ,7 ,8 ]
Gayoso, Jorge [1 ]
Bada-Bosch, Teresa [9 ]
Oppenheimer, Federico [10 ]
Moreso, Francesc [11 ]
Lopez-Oliva, Maria O. [12 ]
Melilli, Edoardo [13 ]
Rodriguez-Ferrero, Marisa L. [14 ]
Bravo, Carlos [15 ]
Burgos, Elena [16 ]
Facundo, Carme [17 ]
Lorenzo, Inmaculada [18 ]
Yanez, Inigo [19 ]
Galeano, Cristina [20 ]
Roca, Ana [21 ]
Cabello, Mercedes [22 ]
Gomez-Bueno, Manuel [23 ]
Garcia-Cosio, Ma Dolores [24 ,25 ]
Graus, Javier [26 ]
Llado, Laura [27 ]
de Pablo, Alicia [28 ]
Loinaz, Carmelo [29 ]
Aguado, Beatriz [30 ]
Hernandez, Domingo [31 ,32 ,33 ]
Dominguez-Gil, Beatriz [1 ]
机构
[1] Spanish Natl Transplant Org, Org Nacl Trasplantes, Madrid, Spain
[2] Hosp Univ 12 Octubre, Grp Study Infect Transplantat & Immunocompromised, Spanish Soc Infect Dis & Clin Microbiol SEIMC, Unit Infect Dis,Inst Invest Sanitaria,imas12, Madrid, Spain
[3] Spanish Soc Infect Dis & Clin Microbiol SEIMC, Grp Study Infect Transplantat & Immunocompromi, Madrid, Spain
[4] Hosp Univ Cabuenes, Dept Nephrol, Gijon, Spain
[5] Spanish Soc Nephrol SEN, Gijon, Spain
[6] Hosp del Mar, Dept Nephrol, Barcelona, Spain
[7] Spanish Soc Nephrol SEN, Transplant Working Grp, Barcelona, Spain
[8] REDinREN RD16 0009 0013, Barcelona, Spain
[9] Hosp Univ 12 Octubre, Dept Nephrol, Madrid, Spain
[10] Hosp Clin Barcelona, Dept Nephrol, Barcelona, Spain
[11] Hosp Univ Vall dHebron, Dept Nephrol, Kidney Transplant Unit, Barcelona, Spain
[12] Hosp Univ La Paz, Dept Nephrol, Madrid, Spain
[13] Hosp Univ Bellvitge, Dept Nephrol, Kidney Transplant Unit, Barcelona, Spain
[14] Hosp Gen Univ Gregorio Maranon, Dept Nephrol, Madrid, Spain
[15] Hosp Univ Vall dHebron, Lung Transplant Unit, Dept Pulmonol, Barcelona, Spain
[16] Hosp Badalona Germans Trias & Pujol, Dept Nephrol, Badalona, Spain
[17] Fdn Puigvert, Kidney Transplant Unit, Barcelona, Spain
[18] Complejo Hosp Univ Albacete, Dept Nephrol, Albacete, Spain
[19] Hosp Univ Cruces, Dept Nephrol, Baracaldo, Spain
[20] Hosp Univ Ramon y Cajal, Kidney Transplant Unit, Madrid, Spain
[21] Complejo Hosp Univ Toledo, Dept Nephrol, Toledo, Spain
[22] Hosp Reg Univ Malaga, Dept Nephrol, Malaga, Spain
[23] Hosp Univ Puerta Hierro, Dept Cardiol, Madrid, Spain
[24] Hosp Univ 12 Octubre, Inst Invest Sanitaria, Hosp 12 Octubre, Cardiol Serv,imas12, Madrid, Spain
[25] Ctr Invest Biomed Red Cardiovasc CIBERCV, Madrid, Spain
[26] Hosp Univ Ramon y Cajal, Dept Gastroenterol, Madrid, Spain
[27] Hosp Univ Bellvitge, Liver Transplant Unit, Barcelona, Spain
[28] Hosp Univ 12 Octubre, Dept Pneumol, Lung Transplant Unit, Madrid, Spain
[29] Hosp Univ 12 Octubre, Dept Gen Surg Digest Tract & Abdominal Organ Tran, Transplant Unit, Madrid, Spain
[30] Hosp Univ La Princesa, Transplant Unit, Dept Hematol, Madrid, Spain
[31] Hosp Reg Univ, Dept Nephrol, Malaga, Spain
[32] Inst Invest Biomed Malaga IBIMA, Malaga, Spain
[33] Spanish Soc Transplantat SET, Malaga, Spain
关键词
clinical research; practice; infectious disease; infection and infectious agents ‐ viral; antibiotic; antiviral; clinical decision‐ making; complication; infectious; CORONAVIRUS DISEASE 2019; CLINICAL IMPACT; INFECTION;
D O I
10.1111/ajt.16369
中图分类号
R61 [外科手术学];
学科分类号
摘要
We report the nationwide experience with solid organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients diagnosed with coronavirus disease 2019 (COVID-19) in Spain until 13 July 2020. We compiled information for 778 (423 kidney, 113 HSCT, 110 liver, 69 heart, 54 lung, 8 pancreas, 1 multivisceral) recipients. Median age at diagnosis was 61 years (interquartile range [IQR]: 52-70), and 66% were male. The incidence of COVID-19 in SOT recipients was two-fold higher compared to the Spanish general population. The median interval from transplantation was 59 months (IQR: 18-131). Infection was hospital-acquired in 13% of cases. No donor-derived COVID-19 was suspected. Most patients (89%) were admitted to the hospital. Therapies included hydroxychloroquine (84%), azithromycin (53%), protease inhibitors (37%), and interferon-beta (5%), whereas immunomodulation was based on corticosteroids (41%) and tocilizumab (21%). Adjustment of immunosuppression was performed in 85% of patients. At the time of analysis, complete follow-up was available from 652 patients. Acute respiratory distress syndrome occurred in 35% of patients. Ultimately, 174 (27%) patients died. In univariate analysis, risk factors for death were lung transplantation (odds ratio [OR]: 2.5; 95% CI: 1.4-4.6), age >60 years (OR: 3.7; 95% CI: 2.5-5.5), and hospital-acquired COVID-19 (OR: 3.0; 95% CI: 1.9-4.9).
引用
收藏
页码:1825 / 1837
页数:13
相关论文
共 50 条
  • [1] Covid-19 in Renal Transplant Recipients: Experience of Lithuania
    Miglinas, M.
    Janusaite, M. M.
    Asakiene, E.
    Vareikiene, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 860 - 860
  • [2] COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul
    Demir, Erol
    Uyar, Murathan
    Parmaksiz, Ergun
    Sinangil, Ayse
    Yelken, Berna
    Dirim, Ahmet Burak
    Merhametsiz, Ozgur
    Yadigar, Serap
    Atan Ucar, Zuhal
    Ucar, Ali Riza
    Demir, Mehmet Emin
    Mese, Meral
    Akin, Emin Baris
    Garayeva, Nurana
    Safak, Seda
    Oto, Ozgur Akin
    Yazici, Halil
    Turkmen, Aydin
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (05)
  • [3] COVID-19 in transplant recipients: Multicentric report of Mexican experience
    Sanchez-Cardenas, Monica
    Vasquez-Jimenez, Enzo
    Velazquez-Silva, Ricardo I.
    Vilatoba-Chapa, Mario
    Gomez-Navarro, Benjamin
    Sanchez-Macias, Lucio O.
    Rodriguez-Chagolla, Jose M.
    Garcia-Juarez, Ignacio
    Abraham-Mancilla, Severo M.
    Morales-Buenrostro, Luis E.
    Parra-Avila, Idalia
    Flores-Gama, Cesar
    [J]. ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, : 66 - 74
  • [4] COVID-19 IN LUNG TRANSPLANT RECIPIENTS: A SINGLE CENTER EXPERIENCE
    Sathiyamoorthy, Gayathri
    Girgis, Reda E.
    Krishnan, Sheila
    Murphy, Edward T.
    Camp, Phillip C.
    Hadley, Ryan J.
    [J]. CHEST, 2022, 162 (04) : 546A - 547A
  • [5] COVID-19 in pancreas transplant recipients
    Dube, Geoffrey K.
    Husain, S. Ali
    McCune, Kasi R.
    Sandoval, P. Rodrigo
    Ratner, Lloyd E.
    Cohen, David J.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (06)
  • [6] COVID-19 in kidney transplant recipients
    Gandolfini, Ilaria
    Delsante, Marco
    Fiaccadori, Enrico
    Zaza, Gianluigi
    Manenti, Lucio
    Degli Antoni, Anna
    Peruzzi, Licia
    Riella, Leonardo V.
    Cravedi, Paolo
    Maggiore, Umberto
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (07) : 1941 - 1943
  • [7] COVID-19 in lung transplant recipients: A single-center experience
    Turkkan, Sinan
    Beyoglu, Muhammet Ali
    Sahin, Mehmet Furkan
    Yazicioglu, Alkin
    Tezer Tekce, Yasemin
    Yekeler, Erdal
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (05)
  • [8] Outcomes of COVID-19 in Kidney Transplant Recipients: The Sri Lankan Experience
    Wijayaratne, Dilushi
    Chandrasiri, Suwan
    Gunaratne, Preeni
    Wijewickrama, Eranga
    [J]. INDIAN JOURNAL OF NEPHROLOGY, 2023, 33 (03) : 202 - 205
  • [9] COVID-19 in Lung Transplant Recipients
    Messika, Jonathan
    Eloy, Philippine
    Roux, Antoine
    Hirschi, Sandrine
    Nieves, Ana
    Le Pavec, Jerome
    Senechal, Agathe
    Saint Raymond, Christel
    Carlier, Nicolas
    Demant, Xavier
    Le Borgne, Aurelie
    Tissot, Adrien
    Debray, Marie-Pierre
    Beaumont, Laurence
    Renaud-Picard, Benjamin
    Reynaud-Gaubert, Martine
    Mornex, Jean-Francois
    Falque, Loic
    Boussaud, Veronique
    Jougon, Jacques
    Mussot, Sacha
    Mal, Herve
    [J]. TRANSPLANTATION, 2021, 105 (01) : 177 - 186
  • [10] COVID-19 and kidney transplant recipients
    Abolghasemi, Sara
    Mardani, Masoud
    Sali, Shahnaz
    Honarvar, Negin
    Baziboroun, Mana
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (06)